Case number 1:25-cv-00018
Nexus Pharmaceuticals, LLC v. Hikma Pharmaceuticals USA Inc. et al > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Jun 24, 2025 | N/A | Pro Hac Vice Attorney Kevin J. Boyle for Hikma Pharmaceuticals USA Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (cdd) (Entered: 06/24/2025) (0) |
| Apr 29, 2025 | 19 | ANSWER to 13 Answer to Amended Complaint,, Counterclaim, by Nexus Pharmaceuticals, LLC.(Farnan, Kelly) (Entered: 04/29/2025) (10) |
| Apr 21, 2025 | N/A | Pro Hac Vice Attorney Anna Sonju for Hikma Pharmaceuticals USA Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (cdd) (Entered: 04/21/2025) (0) |
| Apr 16, 2025 | N/A | Pro Hac Vice Attorney Jovial Wong and Charles B. Klein for Hikma Pharmaceuticals USA Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (oam) (Entered: 04/16/2025) (0) |
| Apr 14, 2025 | N/A | Pro Hac Vice Attorney John R. Labbe, Thomas R. Burns, Isha S. Shah for Nexus Pharmaceuticals, LLC added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (cdd) (Entered: 04/14/2025) (0) |
| Apr 10, 2025 | N/A | SO ORDERED, re 17 MOTION for Pro Hac Vice Appearance of Attorney John R. Labbe, Thomas R. Burns, and Isha Shah filed by Nexus Pharmaceuticals, LLC. Signed by Judge Gregory B. Williams on 4/10/2025. (lnb) (Entered: 04/10/2025) (0) |
| Apr 9, 2025 | N/A | SO ORDERED, re 15 MOTION for Pro Hac Vice Appearance of Attorney Charles B. Klein, Jovial Wong, Kevin Boyle, and Anna Sonju filed by Hikma Pharmaceuticals USA Inc. Signed by Judge Gregory B. Williams on 4/9/2025. (lnb) (Entered: 04/09/2025) (0) |
| Apr 9, 2025 | 17 | MOTION for Pro Hac Vice Appearance of Attorney John R. Labbe, Thomas R. Burns, and Isha Shah - filed by Nexus Pharmaceuticals, LLC. (Farnan, Kelly) (Entered: 04/09/2025) (5) |
| Apr 9, 2025 | 18 | Pro Hac Vice Fee - Credit Card Payment received for John R. Labbe, Thomas R. Burns, and Isha Shah. ( re 17 MOTION for Pro Hac Vice Appearance of Attorney John R. Labbe, Thomas R. Burns, and Isha Shah )( Payment of $ 150, receipt number ADEDC-4658276).(Farnan, Kelly) (Entered: 04/09/2025) (0) |
| Apr 8, 2025 | 13 | ANSWER to Amended Complaint, re: 12 Amended Complaint with Jury Demand Defendant Hikma Pharmaceuticals USA Inc.'s Answer, Affirmative Defenses, and Counterclaims to Plaintiff's First Amended Complaint for Patent Infringement, COUNTERCLAIM against Nexus Pharmaceuticals, LLC by Hikma Pharmaceuticals USA Inc..(Gattuso, Dominick) (Entered: 04/08/2025) (30) |
| Apr 8, 2025 | 14 | Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Hikma Pharmaceuticals, PLC for Hikma Pharmaceuticals USA Inc. filed by Hikma Pharmaceuticals USA Inc.. (Gattuso, Dominick) (Entered: 04/08/2025) (1) |
| Apr 8, 2025 | 15 | MOTION for Pro Hac Vice Appearance of Attorney Charles B. Klein, Jovial Wong, Kevin Boyle, and Anna Sonju - filed by Hikma Pharmaceuticals USA Inc.. (Gattuso, Dominick) (Entered: 04/08/2025) (6) |
| Apr 8, 2025 | 16 | Pro Hac Vice Fee - Credit Card Payment received for Charles B. Klein, Jovial Wong, Kevin Boyle, and Anna Sonju. ( re 15 MOTION for Pro Hac Vice Appearance of Attorney Charles B. Klein, Jovial Wong, Kevin Boyle, and Anna Sonju )( Payment of $ 200, receipt number ADEDC-4657569).(Gattuso, Dominick) (Entered: 04/08/2025) (0) |
| Mar 25, 2025 | 12 | Amended Complaint* (1) |
| Feb 24, 2025 | N/A | SO ORDERED, re 11 Stipulation of Dismissal filed by Hikma Pharmaceuticals USA Inc., Party Hikma Pharmaceuticals PLC terminated. Signed by Judge Gregory B. Williams on 2/24/2025. (lnb) (Entered: 02/24/2025) (0) |
| Feb 21, 2025 | 11 | STIPULATION of Dismissal Stipulation and Order Dismissing Defendant Hikma Pharmaceuticals PLC Without Prejudice and Amending Caption to Reflect Same by Hikma Pharmaceuticals USA Inc.. (Gattuso, Dominick) (Entered: 02/21/2025) (4) |
| Jan 31, 2025 | 10 | Affidavit of Mailing Service of process to Hikma Pharmaceuticals PLC. (Attachments: # 1 FedEx Detailed Tracking, # 2 FedEx Proof of Delivery, # 3 Cover Letter)(mpb) (Entered: 01/31/2025) (0) |
| Jan 31, 2025 | N/A | SO ORDERED, re 9 STIPULATION TO EXTEND TIME for Defendant Pharmaceuticals USA Inc. to answer, move or otherwise respond to Plaintiffs Complaint to March 26, 2025 filed by Hikma Pharmaceuticals USA Inc. Signed by Judge Gregory B. Williams on 1/31/2025. (lnb) (Entered: 01/31/2025) (0) |
| Jan 30, 2025 | 9 | STIPULATION TO EXTEND TIME for Defendant Pharmaceuticals USA Inc. to answer, move or otherwise respond to Plaintiffs Complaint to March 26, 2025 - filed by Hikma Pharmaceuticals USA Inc.. (Gattuso, Dominick) (Entered: 01/30/2025) (2) |
| Jan 28, 2025 | 7 | Letter to Randall C. Lohan, Clerk of the Court from Kelly E. Farnan regarding international service of documents. (Farnan, Kelly) (Entered: 01/28/2025) (1) |
| Jan 28, 2025 | 8 | DECLARATION of Christine D. Haynes re 7 Letter by Nexus Pharmaceuticals, LLC. (Haynes, Christine) (Entered: 01/28/2025) (1) |
| Jan 22, 2025 | 6 | SUMMONS Returned Executed by Nexus Pharmaceuticals, LLC.Hikma Pharmaceuticals USA Inc. served on 1/22/2025, answer due 2/12/2025. (Haynes, Christine) (Entered: 01/22/2025) (2) |
| Jan 8, 2025 | N/A | Case Assigned to Judge Gregory B. Williams. Please include the initials of the Judge (GBW) after the case number on all documents filed. (rjb) (Entered: 01/08/2025) (0) |
| Jan 6, 2025 | 1 | Complaint* (1) |
| Jan 6, 2025 | 2 | Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (oam) (Entered: 01/07/2025) (3) |
| Jan 6, 2025 | 3 | Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 11,464,752 B2; 11,426,369 B2; 11,571,398 B1. (oam) (Entered: 01/07/2025) (1) |
| Jan 6, 2025 | 4 | Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Nexus Family Holdings, Inc. for Nexus Pharmaceuticals, LLC filed by Nexus Pharmaceuticals, LLC. (oam) (Entered: 01/07/2025) (1) |
| Jan 6, 2025 | 5 | Summons Issued as to Hikma Pharmaceuticals PLC on 1/6/2025; Hikma Pharmaceuticals USA Inc. on 1/6/2025. (Attachments: # 1 Summons Issued)(oam) (Entered: 01/07/2025) (0) |
